Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
No therapeutics or vaccines currently exist for human coronaviruses (HCoVs). The Severe Acute Respiratory Syndrome-associated coronavirus (SARS-CoV) epidemic in 2002-2003, and the recent emergence of Middle East Respiratory Syndrome coronavirus (MERS-CoV) in April 2012, emphasize the high probabilit...
Main Authors: | Everett Clinton Smith, Hervé Blanc, Matthew C Surdel, Marco Vignuzzi, Mark R Denison |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-08-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC3744431?pdf=render |
Similar Items
-
Correction: Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics.
Published: (2014-07-01) -
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
by: Maria L. Agostini, et al.
Published: (2018-03-01) -
The coronavirus proofreading exoribonuclease mediates extensive viral recombination.
by: Jennifer Gribble, et al.
Published: (2021-01-01) -
Proofreading-Deficient Coronaviruses Adapt for Increased Fitness over Long-Term Passage without Reversion of Exoribonuclease-Inactivating Mutations
by: Kevin W. Graepel, et al.
Published: (2017-11-01) -
Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity.
by: Everett Clinton Smith, et al.
Published: (2013-01-01)